| Prostate Neoplasm studied in …STUDIED_INderived200 of 6,544show all (up to 200) |
|---|
| → studied in | NCT01230866Phase 3 · active not recruiting Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01492972Phase 3 · recruiting Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04736199Phase 3 · completed Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05148156NA · recruiting Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Benign Prostatic Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06011304Phase 3 · completed Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541210NA · recruiting Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06906471Phase 1/Phase 2 · active not recruiting A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100847Phase 1 · active not recruiting Periprostatic Neurolysis in Prostate Cancer · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185165Phase 2 · recruiting An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328516enrolling by invitation Natural History Study of Early Life Exposures in Agriculture (ELEA) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07569926Phase 4 · recruiting Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07574541Phase 2 · not yet recruiting Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686380Phase 2 · recruiting IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07846592not yet recruiting Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (FLASH) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847385NA · recruiting Tractography-Guided Nerve-Sparing in Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034216recruiting Collection of Blood From Patients With Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441089recruiting Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946204Phase 3 · active not recruiting A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257736Phase 3 · active not recruiting An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489318Phase 3 · active not recruiting A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03431350Phase 2 · active not recruiting A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03834493Phase 3 · terminated Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04497844Phase 3 · active not recruiting A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541030active not recruiting Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644770Phase 1 · active not recruiting A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662580Phase 1 · active not recruiting ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706663recruiting Precision-Based Genomics in Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031805active not recruiting PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095089Phase 1 · recruiting A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472817enrolling by invitation Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06496256NA · recruiting Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07515651Phase 2 · not yet recruiting Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment Toxicity · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543757recruiting Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836933NA · not yet recruiting Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844304not yet recruiting CascadeDiagnose Prostate MRI · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01727284NA · enrolling by invitation MR-Guided Cryoablation of Prostate Bed Recurrences · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123758Phase 1 · active not recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02531516Phase 3 · active not recruiting An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592317Phase 1 · active not recruiting A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460977Phase 1 · recruiting A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03523442Phase 1 · active not recruiting A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03767244Phase 3 · active not recruiting A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071236Phase 1/Phase 2 · suspended Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04557059Phase 3 · active not recruiting A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577833Phase 1 · active not recruiting A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077098Phase 1 · completed Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06064149NA · active not recruiting The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136650Phase 3 · recruiting A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06144619suspended Non-Invasive Biomarkers in Prostate Cancer Disease Management · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629779Phase 3 · recruiting A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06754085Phase 3 · completed Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06759701early Phase 1 · recruiting Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06800313Phase 1/Phase 2 · recruiting Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801236Phase 1 · recruiting Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07082920Phase 1 · recruiting A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07126548NA · recruiting A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181161Phase 1/Phase 2 · recruiting Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225946Phase 3 · recruiting A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07319871Phase 1 · recruiting A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339943NA · recruiting Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07377006NA · recruiting Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07451002recruiting A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07510906NA · not yet recruiting Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07657806Phase 1 · recruiting DEC003M in Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07729150NA · recruiting Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746713Phase 1 · recruiting A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832292Phase 2 · recruiting A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085043NA · active not recruiting Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05241860Phase 2 · active not recruiting Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520255Phase 3 · recruiting 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028 · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052306Phase 1 · active not recruiting A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836726Phase 2 · not yet recruiting Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028853Phase 3 · recruiting This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543055Phase 1 · recruiting A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711184Phase 1 · recruiting A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719361Phase 1 · recruiting A Study in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838753Phase 2 · not yet recruiting A Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their Medication to a Single Hormone Therapy, Compared to Continuing Their Current Drugs · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04219059completed MR Radiomic Features in Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06534918NA · recruiting Precise Oncology Interventions in Nutrition and Training (OnPoint) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926283Phase 1 · recruiting A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025369Phase 2 · recruiting Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177937Phase 1 · recruiting A Study of DXC014 in Patients With Advanced Solid Tumors. · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830212Phase 2 · not yet recruiting Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352924active not recruiting Agriculture Health Study · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923221recruiting Collection of Blood From Patients With Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02594202recruiting Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588128recruiting Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06202820NA · recruiting CV CARE: CardioVascular Care in PC Patients · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780670Phase 2/Phase 3 · recruiting Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855277Phase 3 · recruiting Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894511Phase 2 · active not recruiting An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07114601Phase 1 · recruiting A Study of LY4257496 in Participants With Cancer (OMNIRAY) · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570979Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824349Phase 1 · recruiting JUR-003 in Adult Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832617recruiting Protoacoustic Imaging For 3D Mapping · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237026recruiting Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104893Phase 2 · active not recruiting A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04335682Phase 2 · completed Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615845Phase 1 · terminated A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521412Phase 1/Phase 2 · recruiting EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06594887NA · active not recruiting Rectal Spacers Use in Prostate Cancer Radiation Therapy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234981Phase 2 · recruiting PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518888NA · not yet recruiting Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830511Phase 3 · not yet recruiting RIsk aDapted Stereotactic Radiotherapy vs. standarD of Care Radiotherapy in Patients With Prostate Cancer in the Adjuvant or saLvage sEtting With or Without Lymph Node Irradiation (RIDDLELN) - A Phase III Trial · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831824Phase 2/Phase 3 · recruiting Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup]) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053842Phase 2 · completed Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985565NA · active not recruiting Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361798Phase 2 · recruiting A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05958082NA · active not recruiting Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06085729Phase 1/Phase 2 · recruiting Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06678126Phase 2 · recruiting Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952803Phase 3 · recruiting A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990880Phase 1/Phase 2 · recruiting A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174063Phase 1 · active not recruiting A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365995Phase 3 · recruiting A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548164Phase 3 · recruiting Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829068NA · active not recruiting Brief Title: INTROSPECT: Intraoperative PSMA PET/CT Imaging During Radical Prostatectomy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415621early Phase 1 · completed Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704832NA · completed Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04556045NA · completed Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003752Phase 1/Phase 2 · active not recruiting Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011188Phase 1/Phase 2 · active not recruiting FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011383Phase 2 · recruiting High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05155046Phase 2 · recruiting 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616650Phase 2 · recruiting Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665738NA · recruiting Two-fraction HDR Monotherapy for Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705921NA · active not recruiting Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06284304NA · completed A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353386Phase 1/Phase 2 · recruiting Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568094Phase 1/Phase 2 · recruiting A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06582446Phase 2 · recruiting Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925737Phase 3 · recruiting A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07666217active not recruiting CoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical Prostatectomy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691697recruiting PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813637Phase 1 · recruiting Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07826858NA · recruiting SPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01834001recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02526797enrolling by invitation Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03543189Phase 1/Phase 2 · completed Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03648359NA · enrolling by invitation Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04808427NA · suspended Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06080113NA · enrolling by invitation Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380738active not recruiting Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332455Phase 1/Phase 2 · recruiting First-Time-in-Human Study of GSK5471713 in Adults With mCRPC · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549256Phase 2 · recruiting Cannabidiol for Pain Relief of Patients With End-stage mCRPC · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608718Phase 2 · not yet recruiting Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821775completed Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02522715Phase 1/Phase 2 · active not recruiting Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697148NA · active not recruiting Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104529NA · recruiting Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04286386withdrawn Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585750Phase 1/Phase 2 · recruiting The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995198recruiting PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059236Phase 2 · completed A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05670106Phase 2 · completed A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712473active not recruiting An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751941Phase 2 · active not recruiting Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06150417Phase 2 · recruiting MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06435871NA · completed Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06762379recruiting Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06772441Phase 2 · recruiting Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06970275recruiting To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery. · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06986083Phase 3 · recruiting A Study of Changes to Prostate Procedures · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07084779NA · recruiting Investigation of Impact of AI on Prostate Cancer Workflow · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296042NA · not yet recruiting Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332000Phase 2 · recruiting A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493512Phase 1 · recruiting Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581184Phase 1 · recruiting A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped PROBABILISTIC · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07610083not yet recruiting A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649122Phase 3 · recruiting This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer. · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690306enrolling by invitation Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819760NA · not yet recruiting Radical Prostatectomy Without Prior Biopsy · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820566recruiting Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers) · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525720Phase 2 · active not recruiting Brachytherapy for Prostatic Carcinoma Patients · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769223active not recruiting Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03042468Phase 1/Phase 2 · completed Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905069NA · active not recruiting Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06111781Phase 2 · recruiting The SUGAR Study; SBRT and Relugolix) for Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06451614NA · active not recruiting SpaceIT Hydrogel System for Perirectal Spacing · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |